《新股消息》嗶哩嗶哩(09626.HK)明日起招股 入場費19,959.12元
嗶哩嗶哩(09626.HK)(BILI.US)公布招股詳情,將於明日(18日)起至下周二(23日)招股,計劃於3月29日上市。摩根士丹利、高盛、摩根大通及瑞銀證券為聯席保薦人。
是次IPO將發行2,500萬股Z類股份,當中3%即約75萬股在港公開發售,其餘97%即2,425萬股為國際配售部分,香港部分佔比最多重新分配至300萬股,即約佔發行規模12%,另設15%超額配股權。
香港發售價將不超過每股988元,或每股Z類普通股127.2美元,每股美國存託股等同1股Z類普通股,以16日美股收市價113.31美元計溢價逾12%,集資最多247億元。每手20股入場費為19,959.12元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.